Insulin is a mainstay in type 1 diabetes (T1D) and due to the progressive nature of type 2 diabetes (T2D), insulin is commonly required. However, insulin can involve complex regimens and a high burden of injections and monitoring, which can lead to patient non-adherence and non-persistence. Additionally, clinical inertia can serve as a barrier to initiating, intensifying, and titrating basal insulin therapy, leading to suboptimal glucose management and an increased risk for diabetes-related morbidity and mortality.
Once-weekly basal insulin therapies may provide a patient-centered treatment to overcome these barriers, ideally improving adherence, persistence, patient satisfaction, quality of life, and patient outcomes. Pharmacists can play an important role in understanding the current clinical evidence and ensuring these agents are appropriately used once they become available. This activity will discuss the most recent clinical evidence surrounding once-weekly basal insulin therapies, their potential role in helping overcome clinical inertia, the differences between once-daily and once-weekly basal insulins, and opportunities to dispel misconceptions related to these emerging therapies. Additionally, this activity will include interactive case presentations throughout the activity.
*Please note, this activity was presented as a live webinar. You can only claim credit once for this activity; live or home study.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Susan Cornell, PharmD, CDCES, FAPhA, FADCES Experiential Education Specialist, Adjunct Professor – Midwestern University College of Pharmacy Diabetes Care and Education Specialist and Consultant – Bolingbrook Christian Health Clinic - Bolingbrook, IL, Will-Grundy Medical Clinic - Joliet, IL Downers Grove, Illinois
Susan Cornell, PharmD, CDCES, FAPhA, FADCES is an Experiential Education Specialist and Professor Emeritus at Midwestern University College of Pharmacy in Downers Grove, Illinois. Dr. Cornell is also a clinical pharmacist, consultant and certified diabetes care and education specialist. Her current clinical practice is with the Bolingbrook Christian Health Center and the Will-Grundy Medical Clinic, where she supervises student pharmacists, as they provide medication therapy management and diabetes care and education for underserved populations. Dr. Cornell served as President of the Illinois Pharmacists Association in 2011. She has received numerous awards and recognitions, including the 2024 APhA-ASP Outstanding Chapter Advisor Award, 2022 ADCES Allene Von Son Distinguished Serves Award, the 2021, 2019 and 2011 MWU Outstanding Faculty Advisor, 2017 ADCES Outstanding Illinois Diabetes Educator of the Year, and the 2014 Bowl of Hygeia, to list a few. She is an active member of the American Diabetes Association. She is also actively involved with the Association of Diabetes Care and Education Specialists, where she previously served on their board of directors and continues to assist on various committees. Dr. Cornell has been invited to give numerous presentations to various healthcare professionals and community groups worldwide. She has served as editor, as well as, published and contributed to many peer-reviewed, professional written and online publications. Dr. Cornell is the associate editor of the ADCES Art and Science of Diabetes Care and Education Desk Reference- 3rd thru 6th edition.
Jennifer Trujillo, PharmD, BCPS, BC-ADM, CDCES, FCCP Professor University of Colorado Skaggs School of Pharmacy Aurora, Colorado
Jennifer Trujillo, PharmD, BCPS, BC-ADM, CDCES, FCCPis a Professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in Aurora, Colorado. She practices as a clinical pharmacist and certified diabetes care and education specialist at the University of Colorado Diabetes and Endocrinology Clinic. Her clinical and scholarly interests focus on optimizing diabetes treatment strategies and improving patient access to medications and technology. She teaches diabetes pharmacotherapy and advanced diabetes management in the Doctor of Pharmacy program and is deeply passionate about educating future health care professionals on the power of collaboration, empathy, shared decision-making, and a person-centered approach to diabetes care.
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
The following persons in control of this activity’s content have relevant financial relationships:
Susan Cornell: Advisory Board – NovoNordisk, Inc; Speaker Bureau–Boehringer Ingelheim Pharmaceuticals, Inc.
All other persons in control of content do not have any relevant financial relationships with an ineligible company.
As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity.
To receive CE credit, complete the steps below within 60 days of completing the activity.
Complete pre-work
View the entire presentation
Click "Complete Activity" on last slide then complete the post-work to claim credit.
Verify credits were successfully transferred to CPE Monitor before the ACPE 60-day deadline by checking your NABP eProfile account.
Important Note – ACPE 60 Day Deadline Per ACPE requirements, CPE credit must be claimed within 60 days of being earned – no exceptions! To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, we encourage you to check your NABP eProfile account to validate your credits were transferred successfully before the ACPE 60-day deadline. After the 60 day deadline, ASHP will no longer be able to award credit for this activity.
